What We Do
SFC Fluidics seeks to become a leader in the $9B insulin delivery market by bringing healthcare closer to patients with diabetes. Using proprietary micro-fluidics, the Company is developing a connected, wearable drug dosing system that automates insulin delivery, which in turn allows patients with diabetes to live an active lifestyle while avoiding serious complications such as blindness, amputation, and heart disease.
Anthony Cruz - Chief Executive Officer
Mr. Cruz has over 25 years’ experience in life sciences & medical devices. Prior posts include VP-Business Development and Strategy at Covidien Surgical Devices (now Medtronic) and Business Director at Becton Dickinson’s Diagnostics Division. He has played leadership roles in two successful biotechnology start-ups with both eventually reaching the public markets, each with significant market valuation. Mr. Cruz, a former US Air Force officer, has a B.S. degree in Chemical Engineering from Tufts University and an MBA from Stanford Graduate School of Business.
Gregory Lamps - Consulting Head of R&D
Mr. Lamps is responsible for the later-stage development of the Company’s products. Prior to SFC, Mr. Lamps was Head of R&D at Facet Technologies leading product development for the diabetes market. Greg has a B.S. in Mechanical Engineering and M.S. degree in Manufacturing Systems Engineering from Stanford University and an MBA degree from the Stanford Graduate School of Business.
Barry Ginsberg, MD, PhD - Consulting Medical Director
Dr. Ginsberg is an internationally-recognized expert in diabetes. He was VP for Worldwide Medical Affairs for the Diabetes Division of Becton Dickinson. Barry has served on the board of directors of the American Diabetes Association and as president of the board of directors of the ADA (Iowa Affiliate). He has an undergraduate degree with highest honors in chemistry from Harpur College, SUNY Binghamton and an MD and PhD in Molecular Biology from Albert Einstein College of Medicine.